StockTake: Recce Pharmaceuticals secures $5.3 million R&D cash tax rebate

Recce Pharmaceuticals has secured a cash refund of more than $5.3 million under the Australian Government’s R&D Tax Incentive. ... Read More The post StockTake: Recce Pharmaceuticals secures $5.3 million R&D cash tax rebate appeared first on Stockhead .